BRIEF-Biohaven Pharmaceuticals Q2 loss per share ‍$1.78​
Aug 14 (Reuters) - Biohaven Pharmaceutical Holding Company Ltd
* Biohaven Pharmaceuticals reports second quarter 2017 financial and business results
* Qtrly loss per share ‍$1.78​
* Biohaven Pharmaceuticals- ‍cash as of June 30, 2017 was $204.3 million, compared to $52.3 million as of March 31, 2017​ Source text for Eikon: Further company coverage: